Objective To investigate the protective effect of ethanol extract from Evodia officinalis Dode(EEEO) in a rat model of acute hepatic necrosis induced by carbon tetrachloride (CCl4).Methods Wistar rats were divided into four groups (control,CCl4,EEEO + CCl4,and Silmyarin + CCl4),the four groups were given intragastrically with normal saline,EEEO for 5 d,respectively.In the last one day,these groups except for control group were injected peritoneally with CCl4.Serum levels of alanine aminotransferase (ALT),aspartate aminotransferase (AST),alkaline phosphatase (ALP) were detected by automatic biochemistry analyzer.Pathological changes of hepatic tissues were assessed by hematoxylin-eosine (HE) staining.The levels of superoxide dismutase (SOD),catalase (CAT) and malondialdehyde (MDA) in liver homogenate were analyzed using xanthinoxidase and thio-barbituric acid,respectively.Results Compared the ALT [(345.4 ±51.6)U/ml] and AST [(621.7 ± 143.5) U/ml)] of CCl4 group with ALT [(41.1 ± 2.2) U/ml] and AST [(85.2 ± 22.2) U/ml] of control group,the serum levels of ALT and AST in the CCl4 group were increased significantly (P ＜ 0.05).HE staining of liver tissue,the degeneration and necrosis were implicated to the whole hepatic lobules in the CCl4 group.In EEEO + CCl4 group,compared the ALT [(308.1 ± 44.6) U/ml] and AST [(546.4 ± 131.6) U/ml] of low dose EEEO + CCl4 group with the ALT [(210.6 ±34.5) U/ml] and AST [(379.3 ± 112.3) U/ml] of high dose EEEO +CCl4 group the serum levels of ALT and AST were decreased significantly in low dose EEEO + CCl4 group (P ＜0.05).The denaturation and necrosis of hepatic lobules,the level of SOD,CAT were increased and MDA decreased (P ＜ 0.05) inendochylema.Concluslons EEEO can significantly relieve the CCl4-induced hepatonecrosis.The role may be related to anti-lipid peroxidation.

PURPOSE: Cathepsin K is a potent collagenase implicated in human and animal atherosclerosis-based vascular remodeling. This study examined the hypothesis that serum CatK is associated with the prevalence of coronary artery disease (CAD). MATERIALS AND METHODS: Between January 2011 and December 2012, 256 consecutive subjects were enrolled from among patients who underwent coronary angiography and percutaneous coronary intervention treatment. A total of 129 age-matched subjects served as controls. RESULTS: The subjects' serum cathepsin K and high sensitive C-reactive protein (hs-CRP) and high-density lipoprotein cholesterol were measured. The patients with CAD had significantly higher serum cathepsin K levels compared to the controls (130.8+/-25.5 ng/mL vs. 86.9+/-25.5 ng/mL, p<0.001), and the patients with acute coronary syndrome had significantly higher serum cathepsin K levels compared to those with stable angina pectoris (137.1+/-26.9 ng/mL vs. 102.6+/-12.9 ng/mL, p<0.001). A linear regression analysis showed that overall, the cathepsin K levels were inversely correlated with the high-density lipoprotein levels (r=-0.29, p<0.01) and positively with hs-CRP levels (r=0.32, p<0.01). Multiple logistic regression analyses shows that cathepsin K levels were independent predictors of CAD (odds ratio, 1.76; 95% confidence interval, 1.12 to 1.56; p<0.01). CONCLUSION: These data indicated that elevated levels of cathepsin K are closely associated with the presence of CAD and that circulating cathepsin K serves a useful biomarker for CAD.
Aged ; Biological Markers/blood ; C-Reactive Protein/metabolism ; Cathepsin K/*blood ; Coronary Artery Disease/*blood/metabolism ; Female ; Humans ; Male ; Middle Aged

PURPOSE: Cathepsin K is a potent collagenase implicated in human and animal atherosclerosis-based vascular remodeling. This study examined the hypothesis that serum CatK is associated with the prevalence of coronary artery disease (CAD). MATERIALS AND METHODS: Between January 2011 and December 2012, 256 consecutive subjects were enrolled from among patients who underwent coronary angiography and percutaneous coronary intervention treatment. A total of 129 age-matched subjects served as controls. RESULTS: The subjects' serum cathepsin K and high sensitive C-reactive protein (hs-CRP) and high-density lipoprotein cholesterol were measured. The patients with CAD had significantly higher serum cathepsin K levels compared to the controls (130.8+/-25.5 ng/mL vs. 86.9+/-25.5 ng/mL, p<0.001), and the patients with acute coronary syndrome had significantly higher serum cathepsin K levels compared to those with stable angina pectoris (137.1+/-26.9 ng/mL vs. 102.6+/-12.9 ng/mL, p<0.001). A linear regression analysis showed that overall, the cathepsin K levels were inversely correlated with the high-density lipoprotein levels (r=-0.29, p<0.01) and positively with hs-CRP levels (r=0.32, p<0.01). Multiple logistic regression analyses shows that cathepsin K levels were independent predictors of CAD (odds ratio, 1.76; 95% confidence interval, 1.12 to 1.56; p<0.01). CONCLUSION: These data indicated that elevated levels of cathepsin K are closely associated with the presence of CAD and that circulating cathepsin K serves a useful biomarker for CAD.
Aged ; Biological Markers/blood ; C-Reactive Protein/metabolism ; Cathepsin K/*blood ; Coronary Artery Disease/*blood/metabolism ; Female ; Humans ; Male ; Middle Aged